184 related articles for article (PubMed ID: 9413159)
1. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
Yang YW; Chang YH
Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
[TBL] [Abstract][Full Text] [Related]
2. Effects of doxorubicin on pp60c-src kinase activity in polyoma virus MT antigen transformed cells.
Yang YW; Chang YH
Anticancer Res; 1994; 14(6B):2529-35. PubMed ID: 7532928
[TBL] [Abstract][Full Text] [Related]
3. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Garcia R; Parikh NU; Saya H; Gallick GE
Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of pp60c-src tyrosyl kinase activity in polyoma virus-infected mouse cells is closely associated with polyoma middle tumor antigen synthesis.
Bolen JB; Lewis AM; Israel MA
J Cell Biochem; 1985; 27(2):157-67. PubMed ID: 2580850
[TBL] [Abstract][Full Text] [Related]
5. Analysis of polyomavirus middle-T-antigen-transformed rat cell variants expressing different levels of pp60c-src.
Bolen JB; Amini S; DeSeau V; Reddy S; Shalloway D
J Virol; 1987 Apr; 61(4):1079-85. PubMed ID: 2434664
[TBL] [Abstract][Full Text] [Related]
6. Transformation by polyoma virus middle T antigen.
Courtneidge SA
Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
[TBL] [Abstract][Full Text] [Related]
7. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
Jelinek MA; Hassell JA
Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
[TBL] [Abstract][Full Text] [Related]
8. Changes in cytoskeletal organization in polyoma middle T antigen-transformed fibroblasts: involvement of protein phosphatase 2A and src tyrosine kinases.
da Costa SR; Wang Y; Vilalta PM; Schönthal AH; Hamm-Alvarez SF
Cell Motil Cytoskeleton; 2000 Dec; 47(4):253-68. PubMed ID: 11093247
[TBL] [Abstract][Full Text] [Related]
9. Analysis of middle tumor antigen and pp60c-src interactions in polyomavirus-transformed rat cells.
Bolen JB; DeSeau V; O'Shaughnessy J; Amini S
J Virol; 1987 Oct; 61(10):3299-305. PubMed ID: 2442413
[TBL] [Abstract][Full Text] [Related]
10. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.
Cartwright CA; Hutchinson MA; Eckhart W
Mol Cell Biol; 1985 Oct; 5(10):2647-52. PubMed ID: 2426573
[TBL] [Abstract][Full Text] [Related]
12. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function.
Talmage DA; Riney C; Benjamin TL
Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618
[TBL] [Abstract][Full Text] [Related]
13. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.
Whitesell L; Shifrin SD; Schwab G; Neckers LM
Cancer Res; 1992 Apr; 52(7):1721-8. PubMed ID: 1551101
[TBL] [Abstract][Full Text] [Related]
14. Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.
Pérez L; Paasinen A; Schnierle B; Käch S; Senften M; Ballmer-Hofer K
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8113-7. PubMed ID: 7690142
[TBL] [Abstract][Full Text] [Related]
15. Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.
Bolen JB; Israel MA
J Virol; 1985 Jan; 53(1):114-9. PubMed ID: 2981329
[TBL] [Abstract][Full Text] [Related]
16. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.
Uehara Y; Hori M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Aug; 76(8):672-5. PubMed ID: 3930444
[TBL] [Abstract][Full Text] [Related]
17. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
[TBL] [Abstract][Full Text] [Related]
18. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
Hase H; Isobe A; Kim J
Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
[TBL] [Abstract][Full Text] [Related]
19. Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein.
Chackalaparampil I; Peri A; Nemir M; Mckee MD; Lin PH; Mukherjee BB; Mukherjee AB
Oncogene; 1996 Apr; 12(7):1457-67. PubMed ID: 8622862
[TBL] [Abstract][Full Text] [Related]
20. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.
Murakami Y; Mizuno S; Hori M; Uehara Y
Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
